SightfileU.S. market data from official filings

Companies › APRE

APREA THERAPEUTICS INC (APRE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001781983 · EDGAR filings · Updated 2026-07-23

APREA THERAPEUTICS INC (APRE) has reported institutional ownership of 19.6%, with 22 institutional managers holding positions valued at $1.71M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
19.6%
Institutional managers
22
Reported 13F value
$1.71M
Insider activity
16 trans.
$71.1K net buying
Data flags
2 active
from SEC filings

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, APREA THERAPEUTICS INC has 22 institutional holders and institutional ownership of 19.6%.

Insider activity

Insiders reported 16 transactions (6 buys, 0 sells) across 10 reporting insiders, with a net reported value of $71.1K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-07-23 (recurring since 2020-09-18) — source filing. The authoritative details are those stated in the filing itself.
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-13 (recurring since 2022-05-16) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Dare Bioscience Inc (DARE) · Fresenius SE & Co KGaA (FSNUF) · NANOVIRICIDES INC (NNVC) · REGENTIS BIOMATERIALS LTD (RGNT) · Retractable Technologies Inc (RVP) · Imunon Inc (IMNN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.